CVS Health Co. (NYSE:CVS) Shares Sold by Stifel Financial Corp

Stifel Financial Corp cut its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 1.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 881,804 shares of the pharmacy operator's stock after selling 12,768 shares during the period. Stifel Financial Corp owned approximately 0.07% of CVS Health worth $55,448,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in CVS. MidAtlantic Capital Management Inc. purchased a new position in shares of CVS Health in the third quarter valued at approximately $25,000. Livelsberger Financial Advisory purchased a new position in shares of CVS Health in the third quarter valued at approximately $31,000. Reston Wealth Management LLC purchased a new position in shares of CVS Health in the third quarter valued at approximately $32,000. First Community Trust NA boosted its stake in shares of CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator's stock valued at $33,000 after purchasing an additional 302 shares during the period. Finally, Kathleen S. Wright Associates Inc. purchased a new position in shares of CVS Health in the third quarter valued at approximately $33,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

CVS Health Stock Performance

Shares of CVS Health stock traded down $1.57 during trading on Friday, reaching $55.29. The company's stock had a trading volume of 9,635,184 shares, compared to its average volume of 11,067,306. The company has a 50-day moving average price of $59.32 and a two-hundred day moving average price of $58.78. The firm has a market cap of $69.58 billion, a PE ratio of 14.03, a P/E/G ratio of 0.99 and a beta of 0.54. CVS Health Co. has a fifty-two week low of $52.71 and a fifty-two week high of $83.25. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion for the quarter, compared to analysts' expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health's revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the company posted $2.21 EPS. On average, analysts forecast that CVS Health Co. will post 5.32 EPS for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a $0.665 dividend. The ex-dividend date was Monday, October 21st. This represents a $2.66 annualized dividend and a yield of 4.81%. CVS Health's dividend payout ratio is currently 67.51%.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Cantor Fitzgerald reiterated a "neutral" rating and issued a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st. Evercore ISI lifted their price target on shares of CVS Health from $62.00 to $75.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 8th. Barclays decreased their price target on shares of CVS Health from $75.00 to $71.00 and set an "overweight" rating for the company in a research note on Thursday, November 7th. Wells Fargo & Company upgraded shares of CVS Health from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. Finally, Mizuho reduced their price objective on shares of CVS Health from $73.00 to $66.00 and set an "outperform" rating for the company in a research report on Thursday, October 24th. One analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $70.50.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.